377 related articles for article (PubMed ID: 27012407)
1. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.
Chang TI; Montez-Rath ME; Tsai TT; Hlatky MA; Winkelmayer WC
J Am Coll Cardiol; 2016 Mar; 67(12):1459-1469. PubMed ID: 27012407
[TBL] [Abstract][Full Text] [Related]
2. Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
Vassalli G; Klersy C; De Servi S; Galatius S; Erne P; Eberli F; Rickli H; Hornig B; Bertel O; Bonetti P; Moccetti T; Kaiser C; Pfisterer M; Pedrazzini G;
Am Heart J; 2016 Mar; 173():1-7. PubMed ID: 26920590
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
[TBL] [Abstract][Full Text] [Related]
4. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature.
Athappan G; Ponniah T
Minerva Cardioangiol; 2009 Jun; 57(3):291-7. PubMed ID: 19513010
[TBL] [Abstract][Full Text] [Related]
6. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
8. Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.
Resmini C; Di Cuia M; Ballocca F; D'Ascenzo F; Bollati M; Moretti C; Omedè PL; Sciuto F; Gaita F; Sheiban I
Minerva Cardioangiol; 2012 Dec; 60(6):573-80. PubMed ID: 23147435
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.
Aggarwal V; Stanislawski MA; Maddox TM; Nallamothu BK; Grunwald G; Adams JC; Ho PM; Rao SV; Casserly IP; Rumsfeld JS; Brilakis ES; Tsai TT
J Am Coll Cardiol; 2014 Oct; 64(17):1825-36. PubMed ID: 25443706
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis.
Khera S; Villablanca PA; Kolte D; Gupta T; Hasan Khan M; Velagapudi P; Kalra A; Kleiman N; Aronow HD; Abbott JD; Rosenfield K; Drachman DE; Bangalore S; Bhatt DL; Naidu SS
Cardiol Rev; 2018; 26(6):277-286. PubMed ID: 30157064
[TBL] [Abstract][Full Text] [Related]
13. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
Gordon PC; Cohen DJ; Kleiman NS; Montgomery JA; Semder CA; Kennedy KF; Keyes MJ; Piana RN;
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E356-64. PubMed ID: 22511502
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes following percutaneous coronary intervention before and after introduction of drug-eluting stent.
Naito R; Miyauchi K; Ogita M; Tsuboi S; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
Cardiovasc Interv Ther; 2015 Oct; 30(4):338-46. PubMed ID: 25893655
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease.
Lee MS; Yang T; Kandzari D; Mahmud E; Liao H; Kirtane A
Catheter Cardiovasc Interv; 2012 Oct; 80(4):533-8. PubMed ID: 21953766
[TBL] [Abstract][Full Text] [Related]
16. Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients.
Lenihan CR; Montez-Rath ME; Winkelmayer WC; Chang TI
Transplantation; 2017 Apr; 101(4):851-857. PubMed ID: 27517730
[TBL] [Abstract][Full Text] [Related]
17. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
[TBL] [Abstract][Full Text] [Related]
19. Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study.
Lee HF; Wu LS; Chan YH; Lee CH; Liu JR; Tu HT; Wen MS; Kuo CT; Chen WJ; Yeh YH; See LC; Chang SH
PLoS One; 2016; 11(1):e0146343. PubMed ID: 26731408
[TBL] [Abstract][Full Text] [Related]
20. Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry).
Parikh SV; Saya S; Divanji P; Banerjee S; Selzer F; Abbott JD; Naidu SS; Wilensky RL; Faxon DP; Jacobs AK; Holper EM
Am J Cardiol; 2011 Apr; 107(7):959-64. PubMed ID: 21256469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
